Resolvin D1 ELISA Kit

Confirm delete?

Zoom

Cat No: 500380

Assay Kits - Elisa

Cayman’s Resolvin D1 (RvD1) ELISA Kit is a competitive assay that can be used for quantification of RvD1 (17(S)-Resolvin D1) in plasma, serum, and cell culture supernatants. The assay has a range from 3.3-2,000 pg/ml and a sensitivity (80% B/B0) of ap...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

pain ELISAs enzymes immunoassays kits measures measurements resolvins lipids mediators eicosapentaenoic acids EPAs docosahexaenoic DHA inflammation non-inflamed state oxygenation oxygenated 15-lipoxygenase 5 lipoxygenase 15-LO 5-LO 17(R)-RvD1 17(R) epimers aspirin-treatments configurations humans polymorphonuclear leukocytes PMNL transendothelial migrations acute aspirin-triggered murine mouse mice rat model peritonitis inhibition inhibits inhibitors adjuvant-induced arthritis antihyperalgesic effects prevents attenuates post-operative pains transient receptors potentials TRP channels TRPA1 TRPV3 TRP4 anti-nociceptives phagocytes ALX GPR32 insulin sensitivity leptins (db/db) pro-inflammatory macrophages adipose tissues 10007848 17(S)-RvD1

Product Overview:
Cayman’s Resolvin D1 (RvD1) ELISA Kit is a competitive assay that can be used for quantification of RvD1 (17(S)-Resolvin D1) in plasma, serum, and cell culture supernatants. The assay has a range from 3.3-2,000 pg/ml and a sensitivity (80% B/B0) of approximately 15 pg/ml.

Size	96 strip wells
Shipping	dry ice
Custom Code	3822.00
UNSPSC code	41116104

Technical File

MSDS

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.